Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study1,2

AIMS: The study objective was to investigate the safety and tolerability of up-titration to high doses of taspoglutide, a once-weekly human glucagon-like peptide-1 analogue, in subjects with Type 2 diabetes inadequately controlled on metformin alone. METHODS: In this double-blind phase II trial, sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratner, R, Nauck, M, Kapitza, C, Asnaghi, V, Boldrin, M, Balena, R
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948428/
https://www.ncbi.nlm.nih.gov/pubmed/20536952
http://dx.doi.org/10.1111/j.1464-5491.2010.02990.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948428/
https://www.ncbi.nlm.nih.gov/pubmed/20536952
http://dx.doi.org/10.1111/j.1464-5491.2010.02990.x

Ejemplares similares